Study of Combination Therapy With SYR-322

PHASE3CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Diabetes Mellitus
Interventions
DRUG

Alogliptin

Alogliptin tablets

DRUG

Insulin

Insulin injection

Trial Locations (33)

Unknown

Aomori

Hirosaki-shi

Kashiwa-shi

Kisarazu-shi

Kitakyushu-shi

Aki-gun

Fukuyama-shi

Nishinomiya-shi

Koga-shi

Ushiku-shi

Kahoku-gun

Hanamaki-shi

Morioka

Kagoshima

Satsuma-sendai-shi

Kumamoto

Minamata-shi

Miyazaki

Nigata-shi

Hirakata-shi

Osaka

Osaka-sayama-shi

Takatsuki-shi

Yao-shi

Kuki-shi

Ōtsu

Hamamatsu

Shizuoka

Shimotsuke-shi

Shinagawa-ku

Toyama

Sagae-shi

Yamagata

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY